Alembic Pharmaceuticals News: Read Latest News & Live Updates on Alembic Pharmaceuticals, Photos, Videos at CNBCTV18.com

homeAlembic Pharmaceuticals News

Alembic Pharmaceuticals NEWS

All

market | May 9, 2024 4:52 PM IST
Alembic Pharma Q4 net profit rises 17% driven by strong US sales
market | May 9, 2024 11:01 AM IST
Alembic Pharma gets USFDA nod for five drugs in over a month
market | May 6, 2024 11:29 AM IST
Alembic Pharmaceuticals receives USFDA inspection report for oncology unit in Gujarat
business | Feb 6, 2024 1:07 PM IST
Alembic Pharma targets 5-6 new product launches in US every quarter
market | Feb 5, 2024 5:26 PM IST
Alembic Pharma Q3 net profit rises 48% to ₹180 crore on strong domestic, US sales
healthcare | Sept 13, 2023 11:21 AM IST
US FDA panel deems popular cough and cold ingredient Phenylephrine ineffective
market | Mar 6, 2023 11:08 AM IST
Alembic Pharma gets USFDA approval for colon cancer injection - shares recover from 52-week low
market | Dec 22, 2022 3:34 PM IST
Alembic Pharma receives first USFDA approval for its Jarod Facility’s formulation division IV
market | Oct 18, 2022 1:34 PM IST
Alembic Pharmaceuticals declines as US regulator issues observations to Panelav's facility
earnings | May 2, 2022 7:23 PM IST
Alembic Pharma reports consolidated PAT at Rs 35 crore as revenue declines
earnings | Feb 11, 2022 5:11 PM IST
US biz has bottomed out; injectible plant resolution ongoing: Alembic Pharma
healthcare | Dec 9, 2021 12:39 PM IST
Expect to launch more than 15 products in US next year: Alembic Pharma
earnings | Nov 11, 2021 2:02 PM IST
Alembic Pharma Q2: India business robust; don’t expect further erosion in US market, says management
business | Jul 8, 2021 1:56 PM IST
Alembic Pharmaceuticals gets USFDA nod for anti-depressant drug
earnings | May 5, 2021 2:53 PM IST
Alembic Pharma: Barring Azithromycin drug Azithral 500, don't have much in terms of COVID-related sales

Alembic Pharmaceuticals NEWS

Alembic Pharma Q4 net profit rises 17% driven by strong US sales

Alembic Pharma gets USFDA nod for five drugs in over a month

Alembic Pharmaceuticals receives USFDA inspection report for oncology unit in Gujarat

Alembic Pharma targets 5-6 new product launches in US every quarter

Alembic Pharma Q3 net profit rises 48% to ₹180 crore on strong domestic, US sales

US FDA panel deems popular cough and cold ingredient Phenylephrine ineffective

Alembic Pharma gets USFDA approval for colon cancer injection - shares recover from 52-week low

Alembic Pharma receives first USFDA approval for its Jarod Facility’s formulation division IV

Alembic Pharmaceuticals declines as US regulator issues observations to Panelav's facility

Alembic Pharma reports consolidated PAT at Rs 35 crore as revenue declines

US biz has bottomed out; injectible plant resolution ongoing: Alembic Pharma

Expect to launch more than 15 products in US next year: Alembic Pharma

Alembic Pharma Q2: India business robust; don’t expect further erosion in US market, says management

Alembic Pharmaceuticals gets USFDA nod for anti-depressant drug

Alembic Pharma: Barring Azithromycin drug Azithral 500, don't have much in terms of COVID-related sales